Skip to main content
. 2020 Aug 12;10:1161. doi: 10.3389/fonc.2020.01161

Table 2A.

Immunhistochemical markers.

All patients M0 patients M1 patients p = 0
Marker Nr of patients Nr positiv(%) Nr of patients Nr positiv(%) Nr of patients Nr positiv(%)
CD56 89 87 (98%) 45 45 (100%) 44 42 (96%) 0.99
Chromogranin A 57 36 (63%) 27 19 (70%) 30 17 (57%) 0.28
Synaptophysin 79 63 (80%) 37 33 (89%) 42 30 (71%) 0.06
TTF1 71 64 (90%) 41 37(90%) 30 27 (90%) 0.97
Hif-1-alpha 44 44 (100) 29 29 (100%) 15 15 (100%) n.a.
CD 44 44 44 (100) 29 29 (100%) 15 15 (100%) n.a.
GLUT-1 36 43 (84%) 28 25 (89%) 15 11 (73%) 0.19
PD-1, 18 13 (72%) 12 11 (92%) 6 2 (33%) 0.02
PD-L1 tumor 19 2 (10%) 13 2 (15%) 6 0 (0%) 0.80
PD-L1 stroma 19 6 (32%) 13 5 (38%) 6 1 (17%) 0.36
PD-L1 macrophages 19 12 (63%) 13 10 (76%) 6 2 (33%) 0.08
MIB-1 34 n.a. 12 n.a. 22 n.a. 0.86

n.a., not applicable.